1995
DOI: 10.1016/s0196-0644(95)70289-x
|View full text |Cite
|
Sign up to set email alerts
|

Subcuticular Sutures and the Rate of Inflammation in Noncontaminated Wounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
25
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 4 publications
2
25
0
Order By: Relevance
“…A wide variety of evaluation methods have been described 13,[18][19][20][21][22][23][24] as objective means of histologic assessment of wound healing; yet, no single method is universally accepted. In our study, we attempted to eliminate individual bias by creating a histologic scoring system modeled after that first reported by Sewell et al 12 in 1955.…”
Section: Discussionmentioning
confidence: 99%
“…A wide variety of evaluation methods have been described 13,[18][19][20][21][22][23][24] as objective means of histologic assessment of wound healing; yet, no single method is universally accepted. In our study, we attempted to eliminate individual bias by creating a histologic scoring system modeled after that first reported by Sewell et al 12 in 1955.…”
Section: Discussionmentioning
confidence: 99%
“…Biodegradable and biocompatible polymers, such as poly(lactide‐ co ‐glycolide) (PLGA), have gained much attention and research focus for use in the controlled release of therapeutic proteins. PLGA has been used for many years in various medical applications (i.e., surgical sutures) and the safety of the polymer is well‐established 2–4. A variety of delivery systems, such as microspheres and millicylindrical implants, can be produced using PLGA, and specific release profiles may be generated through manipulating the properties of the polymer 5.…”
Section: Introductionmentioning
confidence: 99%
“…Safe use of this copolymer in suture material and bone fixation devices has been previously described in children (6,7), and similar microsphere systems are currently used in other commercially available sustained release products (8). After sc administration, GH is released from these microspheres in a biphasic manner.…”
Section: He Introduction Of Recombinant Human Ghmentioning
confidence: 99%